Konrad C, Kawamata H, Bredvik KG, Arreguin AJ, Cajamarca SA, Hupf JC, Ravits JM, Miller TM, Maragakis NJ, Hales CM et al..
2017.
Fibroblast bioenergetics to classify amyotrophic lateral sclerosis patients.. Mol Neurodegener. 12(1):76.
Baird-Daniel E, Daniel AGS, Wenzel M, Li D, Liou J-Y, Laffont P, Zhao M, Yuste R, Ma H, Schwartz TH.
2017.
Glial Calcium Waves are Triggered by Seizure Activity and Not Essential for Initiating Ictal Onset or Neurovascular Coupling.. Cereb Cortex. 27(6):3318-3330.
Cole DC, Chung Y, Gagnidze K, Hajdarovic KH, Rayon-Estrada V, Harjanto D, Bigio B, Gal-Toth J, Milner TA, McEwen BS et al..
2017.
Loss of APOBEC1 RNA-editing function in microglia exacerbates age-related CNS pathophysiology.. Proc Natl Acad Sci U S A. 114(50):13272-13277.
Cole DC, Chung Y, Gagnidze K, Hajdarovic KH, Rayon-Estrada V, Harjanto D, Bigio B, Gal-Toth J, Milner TA, McEwen BS et al..
2017.
Loss of APOBEC1 RNA-editing function in microglia exacerbates age-related CNS pathophysiology.. Proc Natl Acad Sci U S A. 114(50):13272-13277.
Sadler R, Singh V, Benakis C, Garzetti D, Brea D, Stecher B, Anrather J, Liesz A.
2017.
Microbiota differences between commercial breeders impacts the post-stroke immune response.. Brain Behav Immun. 66:23-30.
Sadler R, Singh V, Benakis C, Garzetti D, Brea D, Stecher B, Anrather J, Liesz A.
2017.
Microbiota differences between commercial breeders impacts the post-stroke immune response.. Brain Behav Immun. 66:23-30.
Pineda A, Burré J.
2017.
Modulating membrane binding of α-synuclein as a therapeutic strategy.. Proc Natl Acad Sci U S A. 114(6):1223-1225.
Fil D, DeLoach A, Yadav S, Alkam D, MacNicol M, Singh A, Compadre CM, Goellner JJ, O'Brien CA, Fahmi T et al..
2017.
Mutant Profilin1 transgenic mice recapitulate cardinal features of motor neuron disease.. Hum Mol Genet. 26(4):686-701.
Fil D, DeLoach A, Yadav S, Alkam D, MacNicol M, Singh A, Compadre CM, Goellner JJ, O'Brien CA, Fahmi T et al..
2017.
Mutant Profilin1 transgenic mice recapitulate cardinal features of motor neuron disease.. Hum Mol Genet. 26(4):686-701.
Fil D, DeLoach A, Yadav S, Alkam D, MacNicol M, Singh A, Compadre CM, Goellner JJ, O'Brien CA, Fahmi T et al..
2017.
Mutant Profilin1 transgenic mice recapitulate cardinal features of motor neuron disease.. Hum Mol Genet. 26(4):686-701.
Kawamata H, Peixoto P, Konrad C, Palomo G, Bredvik K, Gerges M, Valsecchi F, Petrucelli L, Ravits JM, Starkov A et al..
2017.
Mutant TDP-43 does not impair mitochondrial bioenergetics in vitro and in vivo.. Mol Neurodegener. 12(1):37.